D-Wave’s Q1 Sales Disappoint, but Backlog Shows 2026 Could Be Huge
D-Wave revenue missed but loss smaller; bookings surged to $33.4M from big deals.
Already have an account? Sign in.
D-Wave revenue missed but loss smaller; bookings surged to $33.4M from big deals.
Despite the massive demand boost, analysts remain cautious, citing the company’s $4.9 billion net loss last year and concerns over valuation.
The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.
Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.